| Age: months, mean (range) | 131.2 (4.1–251.4) | 132.4 (10.3–213.1) | NS |
| Sex: M/F, n, | 4/10 | 16/12 | NS |
| Diagnosis of Malignant Disease, n,(%) | 12 (85.7) | 23 (82.1) | NS |
| CR at transplant for malignant disease,n, (%) | 8 (61.5) | 17 (70.8) | NS |
| Donor, n, (%): | | | NS |
| • Sibling HLA identical | 1 (7.2) | 5 (17.9) | |
| • MUD | 7 (50) | 19 (67.8) | |
| • MMUD | 3 (21.4) | 1 (3.6) | |
| • Haploidentical | 3 (21.4) | 3 (10.7) | |
| Stem cell source, n, (%): | | | NS |
| • BM | 12 (85.8) | 26 (92.9) | |
| • PBSC | 1 (7.1) | 2 (7.1) | |
| • CB | 1 (7.1) | 0 (0) | |
| Sex Mismatch, n, (%) | 7 (50) | 15 (53.6) | NS |
| Infused stem cell dose, median (x108 MNC/kg) | 4.71 | 4.66 | NS |
| Conditioning regimens, n, (%): | | | |
| • MAC | 13 (92.9) | 23 (82.1) | NS |
| • With ATG | 10 (71.4) | 20 (71.4) | NS |
| BMI, mean | 17.56 | 18.76 | NS |
| BMI Z-score, mean | −0.37 | −0.06 | NS |
